This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Marco Robello: Innovator in HIV Treatment
Introduction
Marco Robello is a notable inventor based in Washington, DC, who has made significant contributions to the field of medical research. His work primarily focuses on developing innovative compounds for treating serious health conditions, particularly HIV infections.
Latest Patents
Robello holds a patent for the compound N-(3-amino-3-oxopropyl)-2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]benzamide. This compound is designed for treating or preventing human immunodeficiency virus (HIV) infections in mammals. The patent outlines its use in inhibiting or preventing the maturation of immature HIV to a mature form, as well as preventing or inhibiting HIV infections in mammals that have at least one viral particle on a surface.
Career Highlights
Marco Robello is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in this esteemed organization highlights his commitment to advancing public health through innovative research and development.
Collaborations
Robello has collaborated with notable colleagues, including Michael T Scerba and Herman Nikolayevskiy. These partnerships reflect a collaborative approach to tackling complex health challenges.
Conclusion
Marco Robello's contributions to HIV treatment through his patented innovations demonstrate his dedication to improving health outcomes. His work continues to inspire advancements in medical research and treatment options.